MUHLENKAMP & CO INC – Bristol-Myers Squibb Company Transaction History
MUHLENKAMP & CO INC portfolio value:
$9.15M
portfolio value
MUHLENKAMP & CO INC quarter portfolio value change:
-7.68%
quarter
Bristol-Myers Squibb Company 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +0.94% | 1.19K shares | -669K | $71.09 | 128.75K |
Q2 2022 | share | Increase | +0.51% | 650 shares | 554K | $77 | 127.55K |
Q1 2022 | share | Increase | +0.73% | 919 shares | 1.41M | $73.03 | 126.90K |
Q4 2021 | share | Increase | +0.45% | 568 shares | 434K | $62.52 | 125.98K |
Q3 2021 | share | Decrease | -0.16% | -204 shares | -973K | $59.17 | 125.41K |
Q2 2021 | share | Increase | +0.16% | 204 shares | -255K | $65.79 | 125.62K |
Q1 2021 | share | Increase | +0.22% | 281 shares | 887K | $62.15 | 125.41K |
Q4 2020 | share | Increase | +0.73% | 913 shares | 272K | $60.6 | 125.13K |
Q3 2020 | share | Increase | +0.77% | 952 shares | 242K | $58 | 124.22K |
Q2 2020 | share | Increase | +0.04% | 50 shares | -662K | $56.14 | 123.27K |
Q4 2019 | share | Increase | 0.00% | 123.22K shares | 7.91M | $60.36 | 123.22K |
Q2 2018 | share | Decrease | -100.00% | -178.43K shares | -11.28M | $49.59 | 0 |
Q1 2018 | share | Increase | +2.21% | 3.86K shares | 588K | $56.31 | 178.43K |
Q4 2017 | share | Decrease | -1.46% | -2.59K shares | -595K | $54.21 | 174.57K |
Q3 2017 | share | Decrease | -0.45% | -805 shares | 1.37M | $56.04 | 177.16K |
Q2 2017 | share | Decrease | -0.13% | -227 shares | 226K | $48.65 | 177.97K |
Q1 2017 | share | Decrease | -0.42% | -760 shares | -767K | $47.14 | 178.20K |
Q4 2016 | share | Decrease | -0.75% | -1.35K shares | 735K | $50.32 | 178.96K |
Q3 2016 | share | Decrease | -0.56% | -1.02K shares | -3.61M | $46.11 | 180.31K |
Q2 2016 | share | Decrease | -14.54% | -30.86K shares | -217K | $62.9 | 181.34K |
Q1 2016 | share | Increase | +0.21% | 445 shares | -1.01M | $54.35 | 212.2K |